C. Macleod, Entreprises et Histoire n° 36. See also the example of chemistry and pharmaceuticals in Switzerland in the nineteenth century and early twentieth century, 'The patent controversy in the 19 th century, century researchers at the Poulenc laboratory in France took advantage of the non-patentable status of drugs in France to systematically copy German pharmaceutical patents. Cf. Cassier, pp.3-4, 2004.

, Implementation of the Doha Declaration on TRIPS and public health, 2003.

, Conflict over compulsory licences for Efavirenz and Nelfinavir in September 2003 was preceded by a mission by Brazilian chemists to India and China

P. Romer, Two strategies for economic development: using ideas and producing ideas, Proceedings of the World Bank Annual Conference on Development Economics, 1992.

O. ;. Fortunak and J. M. , Academy of Science organized a cycle of conferences on the theme of pharmaceutical policy and innovation. See also the report "Arvs production in Brazil "by Antunes and Fortunak, 8p. CASSIER, M.; CORREA, M. 'Patents, innovation and Public Health: Brazilian Public-Sector Laboratories' Experience in Copying AIDS Drugs' in Economics of Aids Aid and Access in Developing Countries, pp.89-107, 2003.

C. and M. , Brevets pharmaceutiques et santé publique en France entre 1791 et 2004: opposition et dispositions spécifiques d'appropriation des médicaments, revue Entreprises et Histoire, pp.29-47, 2004.

C. and J. C. , COMMISSION ON INTELLECTUAL PROPERTY RIGHTS (CIPR). Integrating property rights and development policy, p.25, 2000.

, GLAXOWELLCOME, Commission on intellectual property rights report on integrating intellectual property rights & development policy: comments from GlaxoSmithKline, p.15, 2002.

L. and J. , The introduction of pharmaceutical products patents in India: heartless exploitation of the poor and suffering? s.l. Economic Growth Center, vol.54, 1997.

. Macleod, Two strategies for economic development: using ideas and producing ideas, pp.3-4, 2005.

, The World Bank, pp.63-91